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Background
Predicting potential drug resistance mutations are impor-
tant when evaluating protein-drug interactions of poten-
tial new antiviral drugs. Here we used evolutionary data
from the Retroviral Aspartyl Protease (RVP) family
(PF00077, 54135 sequences) to estimate plausible PI
resistant-associated AAS within the H1P.
Methods
Using a Hidden Markov Model (HMM) of the RVP family
probabilities were extracted for each possible AAS limited
to the 38 positions reported in the IAS drug resistance list-
ing for H1P (December 2008 version). The HMM is a
dynamic Bayesian network, modeling sequences of amino
acids. The HMM is based on curated and representative
sequences from the RVP family.
Results
Theoretically 760 AAS (20 × 38) are possible for the 38
evaluated positions within the H1P. Of these, the RVP-
HMM detected a total of 229 AAS (30.1%) with a proba-
bility above 1/20 (0.05). Of the 229 AAS, 51 (70%) were
among the 73 AAS included in the IAS listing as PI-resist-
ant mutations, leaving 178 AAS with P > 0.05 as evolu-
tionary plausible.
Conclusion
Based on exploration of the RVP family by HMM, 70% of
the established PI-resistant associated AAS could be pre-
dicted to occur. Additional 178 AAS was identified as evo-
lutionary plausible and potentially could allow for drug-
resistance. In conclusion, we provide a probability land-
scape of plausible/unfavorable AAS based on inherited
structure through evolution and genetic distance, which
could prove useful for future drug design.
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